Positron Emission Tomography with 18F-Fluorodeoxyglucose of Uterine Sarcoma: A Comparison with Magnetic Resonance Imaging and Power Doppler Imaging

Cancer Detection with Whole-Body PET Using 2-[18F]Fluoro-2-Deoxy-D-Glucose

Carl K. Hoh, Randall A. Hawkins, John A. Glaspy et al. · Journal of Computer Assisted Tomography · 1993 · 255 citations

Medicine, Nuclear Medicine, Oncology +17

The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas.

Karl‐Josef Langen, Ursula Braun, Elena Rota Kops et al. · PubMed · 1993 · 200 citations

Medicine, Nuclear Medicine, Oncology +13

Evaluation of FDG PET in patients with cervical cancer.

Yoshifumi Sugawara, Avraham Eisbruch, Shigeru Kosuda et al. · PubMed · 1999 · 185 citations

Medicine, Nuclear Medicine, Radiology +17

Assessment of Primary and Metastatic Ovarian Cancer by Positron Emission Tomography (PET) Using 2-[18F]Deoxyglucose (2-[18F]FDG)

Karl F. Hübner, Thomas W. McDonald, John G. Niethammer et al. · Gynecologic Oncology · 1993 · 177 citations

Medicine, Nuclear Medicine, Oncology +14

Uterine sarcoma: can it be differentiated from uterine leiomyoma with Doppler ultrasonography? A preliminary report

K. Hata, Toshiyuki Hata, Riruke Maruyama et al. · Ultrasound in Obstetrics and Gynecology · 1997 · 69 citations · Full text

Medicine, Oncology, Surgery +17